Long-Term Outcome after Bone Marrow Transplantation for Aplastic Anemia Using Cyclophosphamide and Total Lymphoid Irradiation as Conditioning Regimen

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1, 2008, Pages 43-49

  Inamoto, Yoshihiro ^a   Suzuki, Ritsuro ^a   Kuwatsuka, Yachiyo ^a   Yasuda, Takahiko ^a   Takahashi, Taro ^a   Tsujimura, Akane ^a   Sugimoto, Kyoko ^a   Oba, Taku ^a   Terakura, Seitaro ^a   Atsuta, Yoshiko ^a   Murata, Makoto ^a   Ito, Masafumi ^a   Kodera, Yoshihisa ^a   Miyamura, Koichi ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Aplastic anemia; Bone marrow transplantation; Secondary malignancy; Total lymphoid irradiation

Indexed keywords

ACICLOVIR; ANABOLIC AGENT; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ERYTHROPOIETIN; FLUCONAZOLE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LEVOFLOXACIN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; B LYMPHOCYTE; BLOOD TRANSFUSION; BONE NECROSIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CAPILLARY LEAK SYNDROME; CAUSE OF DEATH; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENGRAFTMENT SYNDROME; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENDER; GRAFT FAILURE; HEMORRHAGIC CYSTITIS; HEPATITIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INAPPROPRIATE VASOPRESSIN SECRETION; INCIDENCE; LYMPH NODE IRRADIATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MONOTHERAPY; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PROGNOSIS; PURE RED CELL ANEMIA; RADIATION PNEUMONIA; RELAPSE; RETROSPECTIVE STUDY; SECOND CANCER; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LONGITUDINAL STUDIES; LYMPH NODES; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 37349123214     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.06.015     Document Type: Article

References (39)

1. Camitta B.M., Thomas E.D., Nathan D.G., et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53 (1979) 504-514
2. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341 (1999) 14-21
3. Socie G., Henry-Amar M., Bacigalupo A., et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 329 (1993) 1152-1157
4. Bacigalupo A., Bruno B., Saracco P., et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 95 (2000) 1931-1934
5. Thomas E.D., Storb R., Fefer A., et al. Aplastic anaemia treated by marrow transplantation. Lancet 1 (1972) 284-289
6. Champlin R.E., Horowitz M.M., van Bekkum D.W., et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 73 (1989) 606-613
7. Sanders J.E. The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team. Semin Hematol 28 (1991) 244-249
8. Gluckman E., Horowitz M.M., Champlin R.E., et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 79 (1992) 269-275
9. Storb R., Etzioni R., Anasetti C., et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84 (1994) 941-949
10. Kojima S. High incidence of graft rejection in children with severe aplastic anemia preconditioned with cyclophosphamide and antithymocyte globulin regimen. Blood 98 Suppl 2 (2001) 376b
11. Abdelkefi A., Ben Othman T., Ladeb S., et al. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center. Hematol J 4 (2003) 208-213
12. Bhatia S., Ramsay N.K., Steinbuch M., et al. Malignant neoplasms following bone marrow transplantation. Blood 87 (1996) 3633-3639
13. Ramsay N.K., Kim T., Nesbit M.E., et al. Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood 55 (1980) 344-346
14. Miyamura K., Kojima S., Takeyama K., et al. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia. Bone Marrow Transplant 3 (1988) 457-461
15. Murata M., Muramoto H., Kojima Y., et al. Hepatic injury localized to the field of total lymphoid irradiation. Bone Marrow Transplant 20 (1997) 897-899
16. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15 (1995) 825-828
17. Sullivan K.M., Agura E., Anasetti C., et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28 (1991) 250-259
18. Hows J.M., Marsh J.C., Yin J.L., et al. Bone marrow transplantation for severe aplastic anaemia using cyclosporin: long-term follow-up. Bone Marrow Transplant 4 (1989) 11-16
19. Gaziev D., Giardini C., Galimberti M., et al. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center. Bone Marrow Transplant 24 (1999) 253-257
20. Champlin R.E., Ho W.G., Nimer S.D., et al. Bone marrow transplantation for severe aplastic anemia: effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy. Transplantation 49 (1990) 720-724
21. Novitzky N., Thomas V., Stubbings H., et al. Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell-depleted stem cell grafts for severe aplasia. Cytotherapy 6 (2004) 450-456
22. Hows J.M., Yin J.L., Marsh J., et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 68 (1986) 1322-1328
23. Kernan N.A., Bartsch G., Ash R.C., et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328 (1993) 593-602
24. Bacigalupo A., Hows J., Gordon-Smith E.C., et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bone Marrow Transplant 3 (1988) 531-535
25. Kahl C., Leisenring W., Deeg H.J., et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol 130 (2005) 747-751
26. Storb R., Blume K.G., O'Donnell M.R., et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant 7 (2001) 39-44
27. Champlin R.E., Perez W.S., Passweg J.R., et al. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood 109 (2007) 4582-4585
28. Bacigalupo A., Locatelli F., Lanino E., et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 36 (2005) 947-950
29. Bitan M., Or R., Shapira M.Y., et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 12 (2006) 712-718
30. Srinivasan R., Takahashi Y., McCoy J.P., et al. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 133 (2006) 305-314
31. Margolis D.A., and Casper J.T. Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol 37 (2000) 43-55
32. Deeg H.J., O'Donnell M., Tolar J., et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 108 (2006) 1485-1491
33. Kojima S., Matsuyama T., Kato S., et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 100 (2002) 799-803
34. Ades L., Mary J.Y., Robin M., et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 103 (2004) 2490-2497
35. Soule B.P., Simone N.L., Savani B.N., et al. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant 40 (2007) 573-578
36. Deeg H.J., Leisenring W., Storb R., et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 91 (1998) 3637-3645
37. Lowsky R., Takahashi T., Liu Y.P., et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 353 (2005) 1321-1331
38. Socie G., Henry-Amar M., Cosset J.M., et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 78 (1991) 277-279
39. Deeg H.J., Socie G., Schoch G., et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87 (1996) 386-392